Search company, investor...

Stage

Debt | Alive

Total Raised

$560K

Last Raised

$60K | 8 yrs ago

About US Telehealth

US Telehealth provides worldwide access to physicians with the latest technology in telecommunications. The company's platform allows a secure virtual connection between physician to patient or physician-to-physician to deliver a wide range of care remotely.

Headquarters Location

1180 Seton Parkway Suite 300

Kyle, Texas, 78640,

United States

888-566-0961

Loading...

Loading...

Expert Collections containing US Telehealth

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

US Telehealth is included in 2 Expert Collections, including Digital Health.

D

Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest US Telehealth News

Neurolief Launches a New U.S. Telehealth Channel Increasing Patient Access to the Relivion MG Migraine Therapy

Mar 1, 2023

News provided by Share this article Share this article TAMPA, Fla., March 1, 2023 /PRNewswire/ -- Neurolief, a medical neurotechnology company, announces the launch of a new Telehealth Channel to enhance patient access to the Relivion MG migraine therapy. Relivion MG is the first and only drug-free, non-invasive wearable migraine therapy that concurrently stimulates both the trigeminal and occipital nerve pathways to provide holistic migraine relief. Relivion is now available through a new telehealth channel on Relivion.com Neurolief's telehealth service is supported by the Relivion Therapy Program and designed specifically for patients seeking a new migraine treatment. These services aim to provide accessible, convenient, and ongoing support for patients. The telehealth service will provide efficient access to online consultations and allow patients to obtain a prescription within 24 hours without ever having to leave their homes. "Migraine affects 40 million Americans every year and we are pleased that this new Telehealth Channel will further expand patient access to Relivion MG. Many migraine patients are seeking non-drug therapies and are looking for a safe electroceutical option to add to their treatment regimen," said Scott Drees, Neurolief's CEO. "This Telehealth service is the next step for Neurolief to empower patients to better manage their life with migraine." Migraine patients often struggle to find support when starting a new therapy. To address this challenge, the Relivion MG Therapy Program provides full-service support for the first 90 days, with a network of trained Relivion Expert Coaches offering one-on-one tailored programs to help patients achieve their treatment goals. "I have lived with migraine for many years and know firsthand how debilitating and isolating this disease can be," says Doug Kane, a Relivion MG patient and advocate. "Having a Relivion coach to support me in reaching my treatment goals and helping me maximize and customize my therapy sessions makes me feel that I am part of a team committed to my treatment success." About Neurolief Neurolief is a neuromodulation company, dedicated to improving the lives of patients suffering from Neurological and Neuropsychiatric disorders such as migraine and depression. The company has designed and manufactures the Relivion device ( www.relivion.com ) which is the world's first neurostimulation system designed to concurrently stimulate the occipital and trigeminal nerve branches to modulate brain regions associated with migraine and depression. Currently FDA and CE approved for the acute treatment of migraine, Relivion is intended to provide a highly effective alternative to pharmaceutical therapies. The system also incorporates a patient mobile app and clinical software with cloud enabled data-tracking feature sets, enabling next generation AI incorporation. The company is currently pursuing additional FDA and CE mark approvals for migraine prevention and for treatment of major depression (MDD). Neurolief Ltd. is headquartered in Netanya Israel, with US operations in Tampa FL, and is made up of highly experienced professionals in neuromodulation technologies, neuroscience, and the medical device industry. SOURCE Neurolief Inc.

US Telehealth Frequently Asked Questions (FAQ)

  • Where is US Telehealth's headquarters?

    US Telehealth's headquarters is located at 1180 Seton Parkway, Kyle.

  • What is US Telehealth's latest funding round?

    US Telehealth's latest funding round is Debt.

  • How much did US Telehealth raise?

    US Telehealth raised a total of $560K.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.